Literature DB >> 1452272

Congenital adrenal hyperplasia: experience at intersex clinic, AIIMS.

P S Menon1, A Virmani, A K Sethi, I C Verma, M Rohatgi, D K Gupta, A K Gupta.   

Abstract

During 1981-88, 63 cases of female pseudohermaphroditism (FPH) were seen at the Intersex clinic at AIIMS, of whom 34 (54%) were diagnosed as due to congenital adrenal hyperplasia (CAH). Though ambiguity was present at birth in most cases, only one child was brought immediately after birth, while 14 presented after one year. Family history of affected siblings and fetal wastage was present in 10. Salt wasting symptoms were present in 13 (38.2%), evidence of early virilization in 10 (29.4%) and generalised hyperpigmentation in 7 (20.6%). Clitoromegaly was present in 30 children with labial fusion in 10 and scrotalisation of labia in 6. The urogenital opening was single in 25 (73.5%). Buccal smear was positive for sex chromatin in 19. Chromosomal pattern showed 46 XX in 33. Dyselectrolytemia was present in 16 children. Bone age was advanced in all. Adrenal hyperplasia could be documented in 3 on CT scan. All the girls were put on hydrocortisone or prednisolone, and fluodrocortisone was given only to children with salt wasting CAH. Children with CAH are being brought to medical attention much too late and investigative and therapeutic facilities are grossly inadequate. There is a need to educate primary care physicians for early case detection and provide minimum diagnostic and therapeutic facilities in regional centres.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1452272     DOI: 10.1007/bf02751571

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  7 in total

Review 1.  Congenital adrenal hyperplasia. (1).

Authors:  P C White; M I New; B Dupont
Journal:  N Engl J Med       Date:  1987-06-11       Impact factor: 91.245

2.  Neonatal screening program for congenital adrenal hyperplasia in a homogeneous Caucasian population.

Authors:  E Cacciari; A Balsamo; A Cassio; S Piazzi; F Bernardi; S Salardi; A Cicognani; P Pirazzoli; F Zappulla; M Capelli
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

3.  Newborn screening for congenital adrenal hyperplasia with special reference to screening in Alaska.

Authors:  S Pang; D A Spence; M I New
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

4.  A pilot newborn screening for congenital adrenal hyperplasia in Alaska.

Authors:  S Pang; W Murphey; L S Levine; D A Spence; A Leon; S LaFranchi; A S Surve; M I New
Journal:  J Clin Endocrinol Metab       Date:  1982-09       Impact factor: 5.958

5.  Growth in congenital adrenal hyperplasia.

Authors:  C G Bergstrand
Journal:  Acta Paediatr Scand       Date:  1966-09

6.  Adult height and fertility in men with congenital virilizing adrenal hyperplasia.

Authors:  M D Urban; P A Lee; C J Migeon
Journal:  N Engl J Med       Date:  1978-12-21       Impact factor: 91.245

7.  Congenital adrenal hyperplasia in Sweden 1969-1986. Prevalence, symptoms and age at diagnosis.

Authors:  A Thilén; A Larsson
Journal:  Acta Paediatr Scand       Date:  1990-02
  7 in total
  4 in total

1.  Congenital adrenal hyperplasia: long-term evaluation of feminizing genitoplasty and psychosocial aspects.

Authors:  D K Gupta; Sharma Shilpa; A C Amini; M Gupta; Gautam Aggarwal; Gupta Deepika; Khatri Kamlesh
Journal:  Pediatr Surg Int       Date:  2006-11       Impact factor: 1.827

Review 2.  Ambiguous genitalia--an Indian perspective.

Authors:  D K Gupta; P S Menon
Journal:  Indian J Pediatr       Date:  1997 Mar-Apr       Impact factor: 1.967

3.  Newborn Screening for Congenital Adrenal Hyperplasia in India: What Do We Need to Watch Out for?

Authors:  R Kishore Kumar; Hari Das; Prakash Kini
Journal:  J Obstet Gynaecol India       Date:  2015-06-11

4.  Growth Pattern and Clinical Profile of Indian Children with Classical 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia on Treatment.

Authors:  H Meena; Manisha Jana; Vishwajeet Singh; Madhulika Kabra; Vandana Jain
Journal:  Indian J Pediatr       Date:  2019-01-30       Impact factor: 1.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.